Urinary neutrophil gelatinase-associated lipocalin: a useful biomarker for tacrolimus-induced acute kidney injury in liver transplant patients
Ayami Tsuchimoto, Haruka Shinke, Miwa Uesugi, Mio Kikuchi, Emina Hashimoto, Tomoko Sato, Yasuhiro Ogura, Koichiro Hata, Yasuhiro Fujimoto, Toshimi Kaido, Junji Kishimoto, Motoko Yanagita, Kazuo Matsubara, Shinji Uemoto, Satohiro Masuda, Ayami Tsuchimoto, Haruka Shinke, Miwa Uesugi, Mio Kikuchi, Emina Hashimoto, Tomoko Sato, Yasuhiro Ogura, Koichiro Hata, Yasuhiro Fujimoto, Toshimi Kaido, Junji Kishimoto, Motoko Yanagita, Kazuo Matsubara, Shinji Uemoto, Satohiro Masuda
Abstract
Tacrolimus is widely used as an immunosuppressant in liver transplantation, and tacrolimus-induced acute kidney injury (AKI) is a serious complication of liver transplantation. For early detection of AKI, various urinary biomarkers such as monocyte chemotactic protein-1, liver-type fatty acid-binding protein, interleukin-18, osteopontin, cystatin C, clusterin and neutrophil gelatinase-associated lipocalin (NGAL) have been identified. Here, we attempt to identify urinary biomarkers for the early detection of tacrolimus-induced AKI in liver transplant patients. Urine samples were collected from 31 patients after living-donor liver transplantation (LDLT). Twenty recipients developed tacrolimus-induced AKI. After the initiation of tacrolimus therapy, urine samples were collected on postoperative days 7, 14, and 21. In patients who experienced AKI during postoperative day 21, additional spot urine samples were collected on postoperative days 28, 35, 42, 49, and 58. The 8 healthy volunteers, whose renal and liver functions were normal, were asked to collect their blood and spot urine samples. The urinary levels of NGAL, monocyte chemotactic protein-1 and liver-type fatty acid-binding protein were significantly higher in patients with AKI than in those without, while those of interleukin-18, osteopontin, cystatin C and clusterin did not differ between the 2 groups. The area under the receiver operating characteristics curve of urinary NGAL was 0.876 (95% confidence interval, 0.800-0.951; P<0.0001), which was better than those of the other six urinary biomarkers. In addition, the urinary levels of NGAL at postoperative day 1 (p = 0.0446) and day 7 (p = 0.0006) can be a good predictive marker for tacrolimus-induced AKI within next 6 days, respectively. In conclusion, urinary NGAL is a sensitive biomarker for tacrolimus-induced AKI, and may help predict renal event caused by tacrolimus therapy in liver transplant patients.
Conflict of interest statement
Competing Interests: The authors have declared that no competing interests exist.
Figures
References
- Masuda S, Inui K (2006) An up-date review on individualized dosage adjustment of calcineurin inhibitors in organ transplant patients. Pharmacol Ther 112: 184–198.
- Barri YM, Sanchez EQ, Jennings LW, Melton LB, Hays S, et al. (2009) Acute Kidney Injury Following Liver Transplantation: Definition and Outcome. Liver Transplantation 15: 475–483.
- Lima EQ, Zanetta DMT, Castro I, Massarollo PCB, Mies S, et al. (2003) Risk factors for development of acute renal failure after liver transplantation. Renal Failure 25: 553–560.
- O'Riordan A, Wong V, McQuillan R, McCormick PA, Hegarty JE, et al. (2007) Acute renal disease, as defined by the RIFLE criteria, post-liver transplantation. American Journal of Transplantation 7: 168–176.
- Cabezuelo JB, Ramirez P, Rios A, Acosta F, Torres D, et al. (2006) Risk factors of acute renal failure after liver transplantation. Kidney International 69: 1073–1080.
- McCauley J, Vanthiel DH, Starzl TE, Puschett JB (1990) Acute and Chronic-Renal-Failure in Liver-Transplantation. Nephron 55: 121–128.
- Vaidya VS, Ferguson MA, Bonventre JV (2008) Biomarkers of acute kidney injury. Annual Review of Pharmacology and Toxicology 48: 463–493.
- Bonventre JV, Vaidya VS, Schmouder R, Feig P, Dieterle F (2010) Next-generation biomarkers for detecting kidney toxicity. Nature Biotechnology 28: 436–440.
- Chariton MR, Wall WJ, Ojo AO, Gines P, Textor S, et al. (2009) Report of the First International Liver Transplantation Society Expert Panel Consensus Conference on Renal Insufficiency in Liver Transplantation. Liver Transplantation 15: S1–S34.
- Nickolas TL, O'Rourke MJ, Yang J, Sise ME, Canetta PA, et al. (2008) Sensitivity and specificity of a single emergency department measurement of urinary neutrophil gelatinase-associated lipocalin for diagnosing acute kidney injury. Annals of Internal Medicine 148: 810–U821.
- Wheeler DS, Devarajan P, Ma D, Harmon K, Monaco M, et al. (2008) Serum neutrophil gelatinase-associated lipocalin (NGAL) as a marker of acute kidney injury in critically ill children with septic shock. Critical Care Medicine 36: 1297–1303.
- Bennett M, Dent CL, Ma Q, Dastrala S, Grenier F, et al. (2008) Urine NGAL predicts severity of acute kidney injury after cardiac surgery: A prospective study. Clinical Journal of the American Society of Nephrology 3: 665–673.
- Mishra J, Dent C, Tarabishi R, Mitsnefes MM, Ma Q, et al. (2005) Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet 365: 1231–1238.
- Niemann CU, Walia A, Waldman J, Davio M, Roberts JP, et al. (2009) Acute Kidney Injury During Liver Transplantation as Determined by Neutrophil Gelatinase-Associated Lipocalin. Liver Transplantation 15: 1852–1860.
- Wagener G, Minhaz M, Mattis FA, Kim M, Emond JC, et al. (2011) Urinary neutrophil gelatinase-associated lipocalin as a marker of acute kidney injury after orthotopic liver transplantation. Nephrology Dialysis Transplantation 26: 1717–1723.
- Negishi K, Noiri E, Sugaya T, Li S, Megyesi J, et al. (2007) A role of liver fatty acid-binding protein in cisplatin-induced acute renal failure. Kidney Int 72: 348–358.
- Manabe K, Kamihata H, Motohiro M, Senoo T, Yoshida S, et al. (2012) Urinary liver-type fatty acid-binding protein level as a predictive biomarker of contrast-induced acute kidney injury. Eur J Clin Invest 42: 557–563.
- Nakamura T, Sugaya T, Koide H (2009) Urinary liver-type fatty acid-binding protein in septic shock: effect of polymyxin B-immobilized fiber hemoperfusion. Shock 31: 454–459.
- Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, et al... (2007) Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Critical Care 11.
- Uesugi M, Kikuchi M, Shinke H, Omura T, Yonezawa A, et al. (2014) Impact of cytochrome P450 3A5 polymorphism in graft livers on the frequency of acute cellular rejection in living-donor liver transplantation. Pharmacogenet Genomics 24: 356–366.
- Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, et al. (2009) Revised Equations for Estimated GFR From Serum Creatinine in Japan. American Journal of Kidney Diseases 53: 982–992.
- Fluss R, Faraggi D, Reiser B (2005) Estimation of the Youden Index and its associated cutoff point. Biom J 47: 458–472.
- Devarajan P (2011) Biomarkers for the early detection of acute kidney injury. Curr Opin Pediatr 23: 194–200.
- Ferguson MA, Vaidya VS, Bonventre JV (2008) Biomarkers of nephrotoxic acute kidney injury. Toxicology 245: 182–193.
- Nishihara K, Masuda S, Shinke H, Ozawa A, Ichimura T, et al... (2013) Urinary chemokine (C-C motif) ligand 2 (monocyte chemotactic protein-1) as a tubular injury marker for early detection of cisplatin-induced nephrotoxicity. Biochem Pharmacol in press.
- Pabla N, Dong Z (2008) Cisplatin nephrotoxicity: mechanisms and renoprotective strategies. Kidney Int 73: 994–1007.
- Peralta CA, Katz R, Bonventre JV, Sabbisetti V, Siscovick D, et al. (2012) Associations of Urinary Levels of Kidney Injury Molecule 1 (KIM-1) and Neutrophil Gelatinase-Associated Lipocalin (NGAL) With Kidney Function Decline in the Multi-Ethnic Study of Atherosclerosis (MESA). American Journal of Kidney Diseases 60: 904–911.
- Gijsen VM, Madadi P, Dube MP, Hesselink DA, Koren G, et al. (2012) Tacrolimus-induced nephrotoxicity and genetic variability: a review. Ann Transplant 17: 111–121.
- McCauley J, Van Thiel DH, Starzl TE, Puschett JB (1990) Acute and chronic renal failure in liver transplantation. Nephron 55: 121–128.
- Fraley DS, Burr R, Bernardini J, Angus D, Kramer DJ, et al. (1998) Impact of acute renal failure on mortality in end-stage liver disease with or without transplantation. Kidney International 54: 518–524.
- Kjeldsen L, Johnsen AH, Sengelov H, Borregaard N (1993) Isolation and Primary Structure of Ngal, A Novel Protein Associated with Human Neutrophil Gelatinase. Journal of Biological Chemistry 268: 10425–10432.
- Cowland JB, Borregaard N (1997) Molecular characterization and pattern of tissue expression of the gene for neutrophil gelatinase-associated lipocalin from humans. Genomics 45: 17–23.
- Mishra J, Ma Q, Prada A, Mitsnefes M, Zahedi K, et al. (2003) Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. Journal of the American Society of Nephrology 14: 2534–2543.
- Mori K, Lee HT, Rapoport D, Drexler IR, Foster K, et al. (2005) Endocytic delivery of lipoccalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury. Journal of Clinical Investigation 115: 610–621.
- Gaspari F, Cravedi P, Mandala M, Perico N, de Leon FR, et al. (2010) Predicting Cisplatin-Induced Acute Kidney Injury by Urinary Neutrophil Gelatinase-Associated Lipocalin Excretion: A Pilot Prospective Case-Control Study. Nephron Clinical Practice 115: C154–C160.
- Hirsch R, Dent C, Pfriem H, Allen J, Beekman RH III, et al... (2007) NGAL is an early predictive biomarker of contrast-induced nephropathy in children. Pediatric Nephrology 22.
- Whiting PH, Thomson AW, Blair JT, Simpson JG (1982) Experimental Cyclosporin a Nephrotoxicity. British Journal of Experimental Pathology 63: 88–94.
- Murray BM, Paller MS, Ferris TF (1985) Effect of Cyclosporine Administration on Renal Hemodynamics in Conscious RATS. Kidney International 28: 767–774.
- Morgan C, Sis B, Pinsk M, Yiu V (2011) Renal interstitial fibrosis in children treated with FK506 for nephrotic syndrome. Nephrol Dial Transplant 26: 2860–2865.
- Ogutmen B, Tuglular S, Cakalagaoglu F, Ozener C, Akoglu E (2006) Transforming growth factor-beta1, vascular endothelial growth factor, and bone morphogenic protein-7 expression in tacrolimus-induced nephrotoxicity in rats. Transplant Proc 38: 487–489.
- Shihab FS, Bennett WM, Tanner AM, Andoh TF (1997) Mechanism of fibrosis in experimental tacrolimus nephrotoxicity. Transplantation 64: 1829–1837.
Source: PubMed